BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32003132)

  • 1. Clinical and surgical outcomes of patients with peritoneal mesothelioma discussed at a monthly national multidisciplinary team video-conference meeting.
    Brandl A; Westbrook S; Nunn S; Arbuthnot-Smith E; Mulsow J; Youssef H; Carr N; Tzivanakis A; Dayal S; Mohamed F; Moran BJ; Cecil T
    BJS Open; 2020 Apr; 4(2):260-267. PubMed ID: 32003132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma and predictors of survival.
    Gilani SNS; Mehta A; Garcia-Fadrique A; Rowaiye B; Jenei V; Dayal S; Chandrakumaran K; Carr N; Mohamed F; Cecil T; Moran B
    Int J Hyperthermia; 2018 Aug; 34(5):578-584. PubMed ID: 29431036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mentored experience of establishing a national peritoneal malignancy programme - Experience of first 50 operative cases.
    Chang KH; Kazanowski M; Staunton O; Cahill RA; Moran BJ; Shields C; Mulsow J
    Eur J Surg Oncol; 2017 Feb; 43(2):395-400. PubMed ID: 27955836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoreductive surgery (CRS) and heated intraperitoneal chemotherapy (HIPEC) for peritoneal mesothelioma: Canadian practices and outcomes.
    Deban M; Taqi K; Knapp GC; Soucisse M; Curry M; Sidéris L; Dubé P; Khaldi MA; Jedrzejko N; Porter G; Giacomantonio C; Hamilton T; MacNeill A; Mack L; Bouchard-Fortier A
    J Surg Oncol; 2023 Sep; 128(4):595-603. PubMed ID: 37249154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Mesothelioma: Experience of a Peritoneal Surface Malignancy Center.
    Aydin N; Sardi A; Milovanov V; Nieroda C; Sittig M; Nunez MF; Jimenez W; Gushchin V
    Am Surg; 2015 Dec; 81(12):1253-9. PubMed ID: 26736164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent or progressive diffuse malignant peritoneal mesothelioma: clinicopathologic characteristics and survival outcome.
    Ihemelandu C; Bijelic L; Sugarbaker PH
    Ann Surg Oncol; 2015 May; 22(5):1680-5. PubMed ID: 25120250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal mesothelioma: preliminary results and survival analysis.
    Hubert J; Thiboutot E; Dubé P; Cloutier AS; Drolet P; Sideris L
    Surg Oncol; 2015 Mar; 24(1):41-6. PubMed ID: 25680983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeat cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent diffuse malignant peritoneal mesothelioma.
    Huang Y; Alzahrani NA; Liauw W; Morris DL
    Eur J Surg Oncol; 2015 Oct; 41(10):1373-8. PubMed ID: 26227745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of multicystic peritoneal mesothelioma treatment with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Zahid A; Clarke L; Carr N; Chandrakumaran K; Tzivanakis A; Dayal S; Mohamed F; Cecil T; Moran BJ
    BJS Open; 2021 Mar; 5(2):. PubMed ID: 33688945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Justified for Biphasic Variants of Peritoneal Mesothelioma? Outcomes from the Peritoneal Surface Oncology Group International Registry.
    Votanopoulos KI; Sugarbaker P; Deraco M; Morris D; Glehen O; Elias D; De Simone M; Robella M; Heyd B; Kusamura S; Baratti D; Chouliaras K; Russell G; Shen P; Levine EA;
    Ann Surg Oncol; 2018 Mar; 25(3):667-673. PubMed ID: 29260418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal malignancy: preliminary results of a multi-disciplinary teamwork model in Asia.
    Wang TY; Chen CY; Lu CH; Chen MC; Lee LW; Huang TH; Hsieh MC; Chen CJ; Yu CM; Chuang HC; Liao TT; Tseng CW; Huang WS
    Int J Hyperthermia; 2018 May; 34(3):328-335. PubMed ID: 28562119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: the Australian experience.
    Chua TC; Yan TD; Morris DL
    J Surg Oncol; 2009 Feb; 99(2):109-13. PubMed ID: 19016259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term regional chemotherapy for patients with epithelial malignant peritoneal mesothelioma results in improved survival.
    Sugarbaker PH; Chang D
    Eur J Surg Oncol; 2017 Jul; 43(7):1228-1235. PubMed ID: 28189456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Peritoneal mesothelioma: treatment with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy].
    Passot G; Cotte E; Brigand C; Beaujard AC; Isaac S; Gilly FN; Glehen O
    J Chir (Paris); 2008; 145(5):447-53. PubMed ID: 19106865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of diagnostic laparoscopy in patients with suspicion of colorectal peritoneal metastases to evaluate suitability for cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
    Hentzen JEKR; van der Plas WY; Constansia RDN; Been LB; Hoogwater FJH; van Ginkel RJ; van Dam GM; Hemmer PHJ; Kruijff S
    BJS Open; 2019 Dec; 3(6):812-821. PubMed ID: 31832588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten-year experience with peritoneal mesothelioma.
    Kyziridis D; Hristakis C; Kalakonas A; Vaikos D; Pallas N; Karamveri C; Kyriakopoulos V; Tentes AA
    J BUON; 2019; 24(1):391-396. PubMed ID: 30941996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive review of childbearing after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Papageorgiou D; Manatakis DK; Papakonstantinou K; Kyriazanos ID
    Arch Gynecol Obstet; 2020 Oct; 302(4):793-799. PubMed ID: 32653946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Referral pathways and outcome of patients with colorectal peritoneal metastasis (CRPM).
    Larentzakis A; O'Dwyer ST; Becker J; Shuweihdi F; Aziz O; Selvasekar CR; Fulford P; Renehan AG; Wilson M
    Eur J Surg Oncol; 2019 Dec; 45(12):2310-2315. PubMed ID: 31433300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for malignant peritoneal mesothelioma.
    Klos D; Hanuliak J; Lemstrova R; Mohelnikova-Duchonova B; Zapletalova J; Melichar B; Risko J
    Bratisl Lek Listy; 2023; 124(5):345-350. PubMed ID: 36876363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneal metastases from small bowel cancer: Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in The Netherlands.
    van Oudheusden TR; Lemmens VE; Braam HJ; van Ramshorst B; Meijerink J; te Velde EA; Mehta AM; Verwaal VJ; de Hingh IH
    Surgery; 2015 Jun; 157(6):1023-7. PubMed ID: 25818658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.